These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8978311)

  • 21. Clinical and Biological Implications of Mutational Spectrum in Acute Myeloid Leukemia of FAB Subtypes M0 and M1.
    Cheng Z; Dai Y; Pang Y; Jiao Y; Zhao H; Wu S; Zhang L; Zhang Y; Wang X; Wang L; Ma D; Qin T; Hu N; Zhang Y; Hu K; Zhang Q; Shi J; Fu L
    Cell Physiol Biochem; 2018; 47(5):1853-1861. PubMed ID: 29961066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flow cytometric analysis of cell-surface and intracellular antigens in the diagnosis of acute leukemia.
    Paredes-Aguilera R; Romero-Guzman L; Lopez-Santiago N; Burbano-Ceron L; Camacho-Del Monte O; Nieto-Martinez S
    Am J Hematol; 2001 Oct; 68(2):69-74. PubMed ID: 11559944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
    Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
    Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical usefulness of immunological marker analysis in adult patients with acute leukaemia.
    Van 't Veer MB; Tetteroo PA; Von dem Borne KR; Engelfriet CP
    Neth J Med; 1985; 28(3):124-7. PubMed ID: 3856755
    [No Abstract]   [Full Text] [Related]  

  • 25. [Classification of acute leukemias].
    Imbert M; Ricard d'Agay MF; André C; Sultan C
    Ann Biol Clin (Paris); 1981; 39(4):155-64. PubMed ID: 6946721
    [No Abstract]   [Full Text] [Related]  

  • 26. Gene expression profiling of minimally differentiated acute myeloid leukemia: M0 is a distinct entity subdivided by RUNX1 mutation status.
    Silva FP; Swagemakers SM; Erpelinck-Verschueren C; Wouters BJ; Delwel R; Vrieling H; van der Spek P; Valk PJ; Giphart-Gassler M
    Blood; 2009 Oct; 114(14):3001-7. PubMed ID: 19666867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
    Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA
    Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunophenotype of clonogenic cells in myeloid leukaemia.
    Kabral A; Bradstock KF; Grimsley P; Favaloro EJ
    Leuk Res; 1988; 12(1):51-9. PubMed ID: 3162752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The immunophenotype of minimally differentiated acute myeloid leukemia (AML-M0): reduced immunogenicity and high frequency of CD34+/CD38- leukemic progenitors.
    Costello R; Mallet F; Chambost H; Sainty D; Arnoulet C; Gastaut JA; Olive D
    Leukemia; 1999 Oct; 13(10):1513-8. PubMed ID: 10516751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
    Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
    Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunologic classification of leukemia and lymphoma.
    Foon KA; Todd RF
    Blood; 1986 Jul; 68(1):1-31. PubMed ID: 2941082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibody anti-MPO is useful in recognizing minimally differentiated acute myeloid leukaemia.
    Praxedes MK; De Oliveira LZ; Pereira Wda V; Quintana IZ; Tabak DG; De Oliveira MS
    Leuk Lymphoma; 1994 Jan; 12(3-4):233-9. PubMed ID: 8167554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minimally differentiated acute myeloid leukemia (AML-M0): comparison of 25 cases with other French-American-British subtypes.
    Venditti A; Del Poeta G; Buccisano F; Tamburini A; Cox MC; Stasi R; Bruno A; Aronica G; Maffei L; Suppo G; Simone MD; Forte L; Cordero V; Postorino M; Tufilli V; Isacchi G; Masi M; Papa G; Amadori S
    Blood; 1997 Jan; 89(2):621-9. PubMed ID: 9002966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoreactivity of MIC2 (CD99) in acute myelogenous leukemia and related diseases.
    Zhang PJ; Barcos M; Stewart CC; Block AW; Sait S; Brooks JJ
    Mod Pathol; 2000 Apr; 13(4):452-8. PubMed ID: 10786814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limitations of the diagnostic criteria for minimally differentiated acute myeloid leukemia (AML-MO).
    Iwata H; Kami M; Kishi Y; Oki Y; Tanaka Y; Takeuchi K; Yamazaki I; Suzuki R; Morinaga S; Mutou Y
    Leukemia; 2000 Nov; 14(11):2013-4. PubMed ID: 11069040
    [No Abstract]   [Full Text] [Related]  

  • 36. Double esterase staining of the bone marrow contributes to lineage identification in a case of minimally differentiated acute myeloid leukaemia (AML M0).
    Elghetany MT
    Clin Lab Haematol; 1999 Aug; 21(4):293-5. PubMed ID: 10583335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered expression of CD45 isoforms in differentiation of acute myeloid leukemia.
    Miyachi H; Tanaka Y; Gondo K; Kawada T; Kato S; Sasao T; Hotta T; Oshima S; Ando Y
    Am J Hematol; 1999 Nov; 62(3):159-64. PubMed ID: 10539882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytogenetic profile in de novo acute myeloid leukemia with FAB subtypes M0, M1, and M2: a study based on 652 cases analyzed with morphology, cytogenetics, and fluorescence in situ hybridization.
    Klaus M; Haferlach T; Schnittger S; Kern W; Hiddemann W; Schoch C
    Cancer Genet Cytogenet; 2004 Nov; 155(1):47-56. PubMed ID: 15527902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minimally differentiated acute myeloid leukemia in Taiwan: predominantly occurs in children less than 3 years and adults between 51 and 70 years.
    Huang SY; Tang JL; Jou ST; Tsay W; Hu CH; Lin DT; Lin KS; Lin KS; Wang CH; Chen YC; Shen MC; Tien HF
    Leukemia; 1999 Oct; 13(10):1506-12. PubMed ID: 10516750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A morphological pattern of 234 cases of leukemias.
    Hassan K; Ikram N; Shah SH
    J Pak Med Assoc; 1994 Jun; 44(6):145-8. PubMed ID: 8089909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.